Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II)
E. L. K. Voogt, S. Nordkamp, A. G. J. Aalbers, T. Buffart, G. J. Creemers, C. A. M. Marijnen, C. Verhoef, K. Havenga, F. A. Holman, M. Kusters, A. W. K. S. Marinelli, J. Melenhorst, N. Abdul Aziz, N. Abecasis, M. Abraham-Nordling, T. Akiyoshi, W. Alberda, M. Albert, M. Andric, E. AngeneteA. Antoniou, R. Auer, K. K. Austin, G. L. Beets, R. G. H. Beets-Tan, M. Berbee, J. Berg, P. L. Berg, J. G. Bloemen, D. Collins, M. Davies, M. de Vries, H. Grabsch, K. Horsthuis, J. Houwers, K. Keymeulen, M. S. Khan, N. F. M. Kok, S. Kumar, P. J. Lee, P. J. Nilsson, S. Oei, A. C. Peterson, H. M. U. Peulen, J. J. G. Slangen, E. J. Tan, L. van Iersel, D. van Zoggel, J. M. W. E. Willems, H. J. T. Rutten, PelvEx Collaborative, J.W.A. Burger*
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II)'. Together they form a unique fingerprint.